ADXS — Ayala Pharmaceuticals Share News
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- $24.30m
- $27.23m
- $0.01m
U.S. STOCKS ON THE MOVE-KE Holdings, Advaxis, DoorDash, Virgin Galactic
Advaxis Inc: Jumps on positive early data from lung cancer treatment study
Brief: Advaxis Announces Receipt Of Second Milestone Payment Under Adxs-Her2 Licensing Agreement With OS Therapies
Brief: Advaxis Inc Announces $20 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
Brief: Advaxis Announces Agreement With Columbia University Irving Medical Center To Fund Phase 1 Study Of Adxs-504 For The Treatment Of Early Prostate Cancer
Brief: Advaxis Reports Q1 Financial Results And Provides A Business Update
Brief: Advaxis Announces Receipt Of Funding Milestone Payment Under ADXS-Her2 Licensing Agreement With OS Therapies
Brief: Advaxis Announces Listing Transfer To Nasdaq Capital Market
U.S. STOCKS ON THE MOVE-Cango, Fuel Tech, Danos Corp, Advaxis
Brief: Advaxis Announces Proposed Public Offering Of Common Stock And Warrants To Purchase Common Stock
Brief: Advaxis Presents Updated Data From Ongoing ADXS-503 Phase 1/2 Lung Cancer Trial At 2020 SITC
Brief: Advaxis ADXS-503 (HOT Lung) Demonstrates Pronounced And Sustained Tumor Control In Ongoing Phase 1/2 Lung Cancer Trial
Brief: Advaxis Says On Oct 6 Co Received Notice From Aratana Therapeutics Dated Sept 17 Indicating That Aratana Terminating Exclusive License Agreement Dated March 19 2014
Brief: Advaxis Adopts Limited Duration Stockholder Rights Plan
Brief: Advaxis Announces FDA Clearance Of New IND For ADXS-504 For Treatment Of Prostate Cancer
Advaxis: Jumps on FDA nod for study of prostate cancer drug
Brief: Advaxis Reports Q3 Loss Per Share Of $0.09
Brief: Advaxis Announces Resignation Of Chief Financial Officer
Brief: Lincoln Park Capital Fund Reports 6.94% Passive Stake In Advaxis